Blog

Muhammad Umair Mushtaq: Successful Use of a Midline Catheter for Leukapheresis in Immune Effector Cell Therapy

Muhammad Umair Mushtaq/LinkedIn

Jan 23, 2025, 02:32

Muhammad Umair Mushtaq: Successful Use of a Midline Catheter for Leukapheresis in Immune Effector Cell Therapy

Muhammad Umair Mushtaq, Associate Professor of Medicine at the University of Kansas Medical Center, shared a post on LinkedIn:

“Successful Use of a Midline Catheter for Leukapheresis in Patients Undergoing Collection for Immune Effector Cell Therapy, Donor Lymphocyte Infusion, and Hematopoietic Progenitor Cell Collection. Journal of Clinical Apheresis. 2025; 40(1): e70004 (PMID: 39810305)”

Successful Use of a Midline Catheter for Leukapheresis in Patients Undergoing Collection for Immune Effector Cell Therapy, Donor Lymphocyte Infusion, and Hematopoietic Progenitor Cell Collection

Authors: Rajat Bansal, Anthony Wiedel, Riley Hastings, Fred Boutz, Haitham Abdelhakim, Nausheen Ahmed, Muhammad Umair Mushtaq, Joseph McGuirk, Sunil Abhyankar

Anthony Wiedel cancer Fred Boutz Haitham Abdelhakim Joseph McGuirk Muhammad Umair Mushtaq Nausheen Ahmed OncoDaily Oncology Rajat Bansal Riley Hastings Sunil Abhyankar

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology